Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.64T | $2.70T | $2.60T | $2.59T | $2.70T | $2.86T | $2.96T | $3.12T |
| Cost of revenue | $2.44T | $2.49T | $2.43T | $2.40T | $2.50T | $2.65T | $2.75T | $2.90T |
| Gross profit | $201.31B | $207.12B | $175.54B | $187.47B | $192.09B | $206.37B | $213.93B | $219.25B |
| Gross margin | 7.6% | 7.7% | 6.7% | 7.3% | 7.1% | 7.2% | 7.2% | 7.0% |
| R&D | $1.25B | $1.40B | $1.44B | $1.37B | $2.09B | $0 | $0 | $0 |
| Operating income | $44.77B | $47.65B | $20.67B | $29.09B | $30.15B | $38.46B | $38.08B | $36.25B |
| EBITDA | $72.09B | $71.11B | $32.54B | $61.08B | $51.96B | $57.44B | $54.56B | $51.39B |
| Net income | $41.70B | $40.27B | $24.50B | $32.18B | $25.79B | $29.56B | $27.39B | $42.01B |
| Net margin | 1.6% | 1.5% | 0.9% | 1.2% | 1.0% | 1.0% | 0.9% | 1.3% |
| EPS (diluted) | 195.79 | 190.26 | 115.75 | 153.57 | 127.42 | 154.13 | 147.54 | 231.68 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $3.21T | $162.96 | $160.78–$165.77 | 1 |
| 2028 | $3.30T | $178.41 | $176.03–$181.49 | 1 |
| 2029 | $3.35T | $179.78 | $177.38–$182.88 | 1 |
| 2030 | $3.55T | $191.53 | $188.97–$194.83 | 1 |
Forward consensus · source: Financial Modeling Prep
ALFRESA HOLDINGS CORP ORD
No one on the platform currently holds ARHCF.
No tracked institution reports a position in ARHCF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $36.0000 | |
| 2026-09-30 | $35.0000 | |
| 2026-03-31 | $34.0000 | 2026-06-02 |
| 2025-09-30 | $34.0000 | 2025-12-05 |
| 2025-03-31 | $32.0000 | 2025-06-03 |
| 2024-09-30 | $31.0000 | 2024-12-05 |
| 2024-03-28 | $5.0000 | 2024-06-04 |
| 2024-03-28 | $31.0000 | 2024-06-04 |
| 2023-09-29 | $5.0000 | 2023-12-05 |
| 2023-09-29 | $29.0000 | 2023-12-05 |
No one on the platform has traded ARHCF yet.
| $5.7B |
| — |
| KKPCFKaken Pharmaceutical Co., Ltd. | $26.00 | +0.00% | $985M | — |
| MITPFMithra Pharmaceuticals S.A. | $23.90 | +254.07% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
| Execution date | Ratio |
|---|---|
| 2014-09-26 | 4-for-1 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.